Anavi System / Ovarian Rebalancing
Ovulation restoration in PCOS patients resistant to first-line oral ovulation induction medications
Key Facts
About May Health
May Health is a clinical-stage medical device company pioneering a modern, interventional approach to treating infertility associated with Polycystic Ovary Syndrome (PCOS). The company's lead product, the Anavi System, is a CE Marked device that performs transvaginal ultrasound-guided ovarian ablation, a procedure intended to lower androgen production and restore ovulation in patients resistant to first-line oral medications. With its pivotal REBALANCE IDE trial currently enrolling in the U.S. to support an FDA submission, May Health is positioned to address a significant unmet need in a large, underserved patient population. The company is backed by prominent European life science investors including Sofinnova Partners and Trill Impact.
View full company profile